RegeneRx Biopharmaceuticals Inc Stock OTC Bulletin Board
Equities
Pharmaceuticals
Financials (USD)
Sales 2021 | 76.76K | Sales 2022 | 76.76K | Capitalization | 19.94M |
---|---|---|---|---|---|
Net income 2021 | -1M | Net income 2022 | -1M | EV / Sales 2021 | 298 x |
Net cash position 2021 | 66.69K | Net Debt 2022 | 1.16M | EV / Sales 2022 | 275 x |
P/E ratio 2021 |
-13.9
x | P/E ratio 2022 |
-11.5
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 55.86% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 86 | 82-05-12 | |
J. Finkelstein
CEO | Chief Executive Officer | 72 | 83-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
J. Finkelstein
CEO | Chief Executive Officer | 72 | 83-12-31 |
Founder | 86 | 82-05-12 | |
Joe McNay
BRD | Director/Board Member | 90 | 01-12-31 |
1st Jan change | Capi. | |
---|---|---|
-4.66% | 87.53B | |
+2.63% | 40.42B | |
-21.76% | 29.48B | |
+57.03% | 25.43B | |
-14.78% | 15.59B | |
-18.49% | 11.49B | |
-15.61% | 11.1B | |
-44.02% | 11.3B | |
+4.64% | 8.75B |